Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA)
CAPS Rating:
The Company is engaged in the discovery and development of breakthrough medicines to treat cancers by regulating cell signaling with small molecules.
The Company is engaged in the discovery and development of breakthrough medicines to treat cancers by regulating cell signaling with small molecules.
Recs
This stock could just be a good pick to do a cover call option for may10 if my figures are right you could see a return of 14% for the month.